Cargando…
Case Report: Effectiveness of secukinumab in systemic sclerosis with early skin progress after autologous hematopoietic stem cell transplantation and end-stage kidney disease
Autologous hematopoietic stem cell transplantation (aHSCT) represents an effective treatment option in patients with severe forms of systemic sclerosis (SSc) by resetting the immune system. Nevertheless, secondary autoimmune disorders and progressive disease after aHSCT might necessitate renewed imm...
Autores principales: | Strunz, Patrick-Pascal, Labinsky, Hannah, Nagler, Lea-Kristin, Portegys, Jan, Froehlich, Matthias, Gernert, Michael, Schmalzing, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693324/ https://www.ncbi.nlm.nih.gov/pubmed/38045701 http://dx.doi.org/10.3389/fimmu.2023.1294496 |
Ejemplares similares
-
Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients
por: Strunz, Patrick-Pascal, et al.
Publicado: (2021) -
Lymphocyte subsets in the peripheral blood are disturbed in systemic sclerosis patients and can be changed by immunosuppressive medication
por: Gernert, Michael, et al.
Publicado: (2021) -
Autologous Stem Cell Transplantation in Common Variable Immunodeficiency: A Case of Successful Treatment of Severe Refractory Autoimmune Encephalitis
por: Froehlich, Matthias, et al.
Publicado: (2020) -
Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients—High Efficacy of Rituximab
por: Gernert, Michael, et al.
Publicado: (2022) -
Low B cell counts as risk factor for infectious complications in systemic sclerosis after autologous hematopoietic stem cell transplantation
por: Gernert, Michael, et al.
Publicado: (2020)